Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma.
Puduvalli VK, Wu J, Yuan Y, Armstrong TS, Vera E, Wu J, Xu J, Giglio P, Colman H, Walbert T, Raizer J, Groves MD, Tran D, Iwamoto F, Avgeropoulos N, Paleologos N, Fink K, Peereboom D, Chamberlain M, Merrell R, Penas Prado M, Yung WKA, Gilbert MR. Puduvalli VK, et al. Among authors: paleologos n. Neuro Oncol. 2020 Oct 14;22(10):1505-1515. doi: 10.1093/neuonc/noaa062. Neuro Oncol. 2020. PMID: 32166308 Free PMC article. Clinical Trial.
Myeloablative chemotherapy for recurrent aggressive oligodendroglioma.
Cairncross G, Swinnen L, Bayer R, Rosenfeld S, Salzman D, Paleologos N, Kaminer L, Forsyth P, Stewart D, Peterson K, Hu W, Macdonald D, Ramsay D, Smith A; Oligodendroglioma Study Group. Cairncross G, et al. Among authors: paleologos n. Neuro Oncol. 2000 Apr;2(2):114-9. doi: 10.1093/neuonc/2.2.114. Neuro Oncol. 2000. PMID: 11303620 Free PMC article.
Treatment of oligodendroglioma: an update.
Paleologos NA, Cairncross JG. Paleologos NA, et al. Neuro Oncol. 1999 Jan;1(1):61-8. Neuro Oncol. 1999. PMID: 11550303 Free PMC article. Review.
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma.
Abrey LE, Childs BH, Paleologos N, Kaminer L, Rosenfeld S, Salzman D, Finlay JL, Gardner S, Peterson K, Hu W, Swinnen L, Bayer R, Forsyth P, Stewart D, Smith AM, Macdonald DR, Weaver S, Ramsey DA, Nimer SD, DeAngelis LM, Cairncross JG. Abrey LE, et al. Among authors: paleologos n. J Neurooncol. 2003 Nov;65(2):127-34. doi: 10.1023/b:neon.0000003645.82791.2a. J Neurooncol. 2003. PMID: 14686732 Clinical Trial.
High-dose chemotherapy with stem cell rescue as initial therapy for anaplastic oligodendroglioma: long-term follow-up.
Abrey LE, Childs BH, Paleologos N, Kaminer L, Rosenfeld S, Salzman D, Finlay JL, Gardner S, Peterson K, Hu W, Swinnen L, Bayer R, Forsyth P, Stewart D, Smith AM, Macdonald DR, Weaver S, Ramsay DA, Nimer SD, DeAngelis LM, Cairncross JG. Abrey LE, et al. Among authors: paleologos n. Neuro Oncol. 2006 Apr;8(2):183-8. doi: 10.1215/15228517-2005-009. Epub 2006 Mar 8. Neuro Oncol. 2006. PMID: 16524945 Free PMC article. Clinical Trial.
Survey of treatment recommendations for anaplastic oligodendroglioma.
Abrey LE, Louis DN, Paleologos N, Lassman AB, Raizer JJ, Mason W, Finlay J, MacDonald DR, DeAngelis LM, Cairncross JG; Oligodendroglioma Study Group. Abrey LE, et al. Among authors: paleologos n. Neuro Oncol. 2007 Jul;9(3):314-8. doi: 10.1215/15228517-2007-002. Epub 2007 Apr 13. Neuro Oncol. 2007. PMID: 17435180 Free PMC article.
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.
Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T. Friedman HS, et al. Among authors: paleologos n. J Clin Oncol. 2009 Oct 1;27(28):4733-40. doi: 10.1200/JCO.2008.19.8721. Epub 2009 Aug 31. J Clin Oncol. 2009. PMID: 19720927 Clinical Trial.
56 results